Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
The bacterial CRISPR/Cas9 system allows sequence-specific gene editing in many organisms and holds promise as a tool to generate models of human diseases, for example, in human pluripotent stem cells. CRISPR/Cas9 introduces targeted double-stranded breaks (DSBs) with high efficiency, which are typically repaired by non-homologous end-joining (NHEJ) resulting in nonspecific insertions, deletions or other mutations (indels). DSBs may also be repaired by homology-directed repair (HDR) using a DNA repair template, such as an introduced single-stranded oligo DNA nucleotide (ssODN), allowing knock-in of specific mutations. Although CRISPR/Cas9 is used extensively to engineer gene knockouts through NHEJ, editing by HDR remains inefficient and can be corrupted by additional indels, preventing its widespread use for modelling genetic disorders through introducing disease-associated mutations. Furthermore, targeted mutational knock-in at single alleles to model diseases caused by heterozygous mutations has not been reported. Here we describe a CRISPR/Cas9-based genome-editing framework that allows selective introduction of mono- and bi-allelic sequence changes with high efficiency and accuracy. We show that HDR accuracy is increased dramatically by incorporating silent CRISPR/Cas-blocking mutations along with pathogenic mutations, and establish a method termed 'CORRECT' for scarless genome editing. By characterizing and exploiting a stereotyped inverse relationship between a mutation's incorporation rate and its distance to the DSB, we achieve predictable control of zygosity. Homozygous introduction requires a guide RNA targeting close to the intended mutation, whereas heterozygous introduction can be accomplished by distance-dependent suboptimal mutation incorporation or by use of mixed repair templates. Using this approach, we generated human induced pluripotent stem cells with heterozygous and homozygous dominant early onset Alzheimer's disease-causing mutations in amyloid precursor protein (APP(Swe)) and presenilin 1 (PSEN1(M146V)) and derived cortical neurons, which displayed genotype-dependent disease-associated phenotypes. Our findings enable efficient introduction of specific sequence changes with CRISPR/Cas9, facilitating study of human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While exogenous DNA can be inserted at the target site through homology-directed repair (HDR) mechanism, successful insertion of exogenous DNA is relatively rare and is likely accompanied by loss of the second allele24.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [24]
In the citing paper
“Briefly, the majority of a HDR template’s homology arm sequences are not incorporated with on-target HDR integrations (Paquet et al., 2016)”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Paquet et al., 2016
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
PEAR: a fast and accurate Illumina Paired-End reAd mergeR
Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Goecks, J., Nekrutenko, A., Taylor, J., & The Galaxy Team (2010) · Genome Biology · doi:10.1186/gb-2010-11-8-r86 · Cited by 3,453
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Cited by
Items 201–300 of 935
Kalds, P., Luo, Q., Sun, K., Zhou, S., Chen, Y., & Wang, X. (2021) · Animal Genetics · doi:10.1111/age.13133 · Cited by 75
APOBEC3 induces mutations during repair of CRISPR–Cas9-generated DNA breaks
Lei, L., Chen, H., Xue, W., Yang, B., Hu, B., Wei, J., Wang, L., Cui, Y., Li, W., Wang, J., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/s41594-017-0004-6 · Cited by 54
In vivo epigenome editing and transcriptional modulation using CRISPR technology
Lau, C., & Suh, Y. (2018) · Transgenic Research · doi:10.1007/s11248-018-0096-8 · Cited by 57
Efficient generation of goats with defined point mutation (I397V) in GDF9 through CRISPR/Cas9
Niu, Y., Zhao, X., Zhou, J., Li, Y., Huang, Y. S., Cai, B., Liu, Y., Ding, Q., Zhou, S., Zhao, J., et al. (2017) · Reproduction Fertility and Development · doi:10.1071/rd17068 · Cited by 55
Imaging pathological activities of human brain tissue in organotypic culture
Duigou, C. L., Savary, E., Morin‐Brureau, M., Gómez-Domínguez, D., Sobczyk, A., Chali, F., Milior, G., Kraus, L., Meier, J. C., Kullmann, D. M., et al. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.02.001 · Cited by 49
Mocciaro, A., Roth, T. L., Bennett, H. M., Soumillon, M., Shah, A., Hiatt, J. B., Chapman, K., Marson, A., & Lavieu, G. (2018) · Communications Biology · doi:10.1038/s42003-018-0034-6 · Cited by 54
Programmable Base Editing of the Sheep Genome Revealed No Genome-Wide Off-Target Mutations
Zhou, S., Cai, B., He, C. Z., Wang, Y., Ding, Q., Liu, J., Liu, Y., Ding, Y., Zhao, X., Li, G., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00215 · Cited by 55
“The non-specificity of the programmable deaminase BE3 often results in short indels and mosaicism (Kim D. et al., 2017; Park et al., 2017; Sasaguri et al., 2018).”
BackgroundNew advances in CRISPR/Cas-mediated precise gene-editing techniques
Richardson, C., Kelsh, R. N., & Richardson, R. J. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049874 · Cited by 57
“Several studies have identified that a silent ‘ blocking ’ mutation within the PAM site of the linearised dDNA, which should prevent re-cutting of the edited locus by residual Cas, increases PGE rates (Okamoto et al., 2019; Paquet et al., 2016; Schubert et al., 2021).”
Targeted Genome Replacement via Homology-directed Repair in Non-dividing Cardiomyocytes
Ishizu, T., Higo, S., Masumura, Y., Kohama, Y., Shiba, M., Higo, T., Shibamoto, M., Nakagawa, A., Morimoto, S., Takashima, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09716-x · Cited by 54
Genetic engineering in primary human B cells with CRISPR-Cas9 ribonucleoproteins
Wu, C.-A. M., Roth, T. L., Baglaenko, Y., Ferri, D., Brauer, P. M., Zúñiga‐Pflücker, J. C., Rosbe, K. W., Wither, J., Marson, A., & Allen, C. D. C. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.03.009 · Cited by 56
Modeling Psychiatric Disorder Biology with Stem Cells
Das, D., Feuer, K. L., Wahbeh, M. H., & Avramopoulos, D. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01148-1 · Cited by 56
Molecular mechanism overview of metabolite biosynthesis in medicinal plants
Li, Z., Wang, Y., Xu, M., Liu, H., Li, L., & Xu, D. (2023) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2023.108125 · Cited by 47
Generation of Artificial Gamete and Embryo From Stem Cells in Reproductive Medicine
Zhang, P.-Y., Fan, Y., Tan, T., & Yu, Y. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00781 · Cited by 51
Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing
Zhang, X., Li, T., Ou, J., Huang, J., & Liang, P. (2021) · Protein & Cell · doi:10.1007/s13238-021-00838-7 · Cited by 51
“To prevent re-cutting of the edited allele, the exogenous DNA donor should contain both the desired sequence change and blocking silent mutations, which will prevent the gRNA-Cas complex from cleaving the edited allele (Paquet et al., 2016; Kwart et al., 2017).”
BackgroundSladen, P. E., Perdigão, P. R. L., Salsbury, G., Novoselova, T. V., van der Spuy, J., Chapple, J. P., Yu‐Wai‐Man, P., & Cheetham, M. E. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.08.015 · Cited by 52
“Following their generation, DOA-iPSCs were corrected using CRISPR-Cas9 gene editing technology combined with a singlestranded DNA (ssDNA) repair template.(31,32) Two CRISPR-Cas9 guides were designed to direct the Cas9 endonuclease to cut as close as possible to theOPA1 c.”
MethodExome Sequencing Reveals the POLR3H Gene as a Novel Cause of Primary Ovarian Insufficiency
França, M. M., Han, X., Funari, M. F. A., Lerário, A. M., Nishi, M. Y., Fontenele, E. G. P., Domenice, S., Jorge, A. A. L., García-Galiano, D., Elias, C. F., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02485 · Cited by 55
Lau, C., Ho, J. W., Lo, P. K., & Tin, C. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.04.015 · Cited by 48
Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes
Vicencio, J., Sánchez-Bolaños, C., Moreno-Sánchez, I., Brena, D., Vejnar, C. E., Kukhtar, D., Ruiz-López, M., Cots-Ponjoan, M., Rubio, A., Melero, N. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30228-4 · Cited by 51
Wang, K., Tang, X., Liu, Y., Xie, Z., Zou, X., Li, M., Yuan, H., Ouyang, H., Jiao, H., & Pang, D. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.101 · Cited by 53
Pluripotent Stem Cells: The Last 10 Years
Kimbrel, E. A., & Lanza, R. (2016) · Regenerative Medicine · doi:10.2217/rme-2016-0117 · Cited by 53
Translational Research: Exploring and Creating Genetic Diversity
Jacob, P., Avni, A., & Bendahmane, A. (2017) · Trends in Plant Science · doi:10.1016/j.tplants.2017.10.002 · Cited by 51
Optimizing a CRISPR-Cpf1-based genome engineering system for Corynebacterium glutamicum
Zhang, J., Yang, F., Yang, Y., Jiang, Y., & Huo, Y. (2019) · Microbial Cell Factories · doi:10.1186/s12934-019-1109-x · Cited by 45
“genome editing A DSB induced by CRISPR-Cpf1 in vivo can be repaired through HR in the presence of a plasmid-borne template [21, 36, 37].”
BackgroundEfficient CRISPR-Cas9-Mediated Knock-In of Composite Tags in Zebrafish Using Long ssDNA as a Donor
Ranawakage, D. C., Okada, K., Sugio, K., Kawaguchi, Y., 盆子原友希, Takada, T., & Kamachi, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.598634 · Cited by 45
“This is supported by the reported monotonic inverse relationship between the rate of point mutation incorporation and distance from the cleavage site, where the rate decreases to approximately 50% with 10 nt (Paquet et al., 2016).”
BackgroundInfluentialPrecise Genome Editing in Poultry and Its Application to Industries
Park, J. S., Lee, K. Y., & Han, J. Y. (2020) · Genes · doi:10.3390/genes11101182 · Cited by 49
“Furthermore, an HDR-dependent knock-in strategy called CORRECT (‘Consecutive Re-guide or Re-Cas steps to Erase CRISPR/Cas-blocked Targets’) has been developed for scarless genome editing [23].”
MethodDrug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases
Hung, S. S. C., Khan, S., Lo, C. Y.-W., Hewitt, A. W., & Wong, R. C. B. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.026 · Cited by 49
Harmsen, T., Klaasen, S. J., van de Vrugt, H., & Riele, H. T. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky076 · Cited by 47
“Note that we added an additional mutation to simultaneously disrupt the PAM sequence in order to prevent recutting by Cas9 and loss of gene correction events (20).”
BackgroundCastrillo, J. I., Lista, S., Hampel, H. J., & Ritchie, C. W. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7704-8_3 · Cited by 46
Human stem cell models to study host–virus interactions in the central nervous system
Harschnitz, O., & Studer, L. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-020-00474-y · Cited by 47
TPC2 rescues lysosomal storage in mucolipidosis type IV, Niemann–Pick type C1, and Batten disease
Rosato, A. S., Krogsaeter, E., Jaślan, D., Abrahamian, C., Montefusco, S., Soldati, C., Spix, B., Pizzo, M. T., Grieco, G., Böck, J., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202115377 · Cited by 47
Self-citationEmerging applications of gene editing technologies for the development of climate-resilient crops
Chavhan, R. L., Jaybhaye, S. G., Hinge, V. R., Deshmukh, A. S., Shaikh, U. S., Jadhav, P. K., Kadam, U. S., & Hong, J. C. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1524767 · Cited by 55
Highly efficient genome editing by homology-directed repair using Cas9 protein in Ceratitis capitata
Aumann, R. A., Schetelig, M. F., & Häcker, I. (2018) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2018.08.004 · Cited by 46
Advances in genome editing for genetic hearing loss
Ding, N., Lee, S., Lieber-Kotz, M., Yang, J., & Gao, X. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.001 · Cited by 45
Optimization of Cas9 activity through the addition of cytosine extensions to single-guide RNAs
Kawamata, M., Suzuki, H. I., Kimura, R., & Suzuki, A. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01011-7 · Cited by 46
“F(WT/R206H_Corrected) = 1 ∫ 0 hP(1 − P′)(1 − P′′)f (P;α,β)dP (22)”
Jusop, A. S., Thanaskody, K., Tye, G. J., Dass, S. A., Zaman, W. S. W. K., & Nordin, F. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1173433 · Cited by 47
Prime editing in plants: prospects and challenges
Vats, S., Kumar, J., Sonah, H., Zhang, F., & Deshmukh, R. K. (2024) · Journal of Experimental Botany · doi:10.1093/jxb/erae053 · Cited by 54
Alariqi, M., Ramadan, M., Yu, L., Hui, F., Hussain, A., Zhou, X., Yu, Y., Zhang, X., & Jin, S. (2025) · Advanced Science · doi:10.1002/advs.202416331 · Cited by 51
GOTI, a method to identify genome-wide off-target effects of genome editing in mouse embryos
Zuo, E., Sun, Y., Wu, W., Yuan, T., Ying, W., Sun, H., Yuan, L., Steinmetz, L. M., Li, Y., & Yang, H. (2020) · Nature Protocols · doi:10.1038/s41596-020-0361-1 · Cited by 45
Akella, S., Ma, X., Bačová, R., Harmer, Z. P., Koláčková, M., Wen, X., Wright, D. A., Spalding, M. H., Weeks, D. P., & Cerutti, H. D. (2021) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiab418 · Cited by 45
Bodai, Z., Bishop, A. L., Gantz, V. M., & Komor, A. C. (2022) · Nature Communications · doi:10.1038/s41467-022-29989-9 · Cited by 50
Paving the way towards precise and safe CRISPR genome editing
Śledziński, P., Dabrowska, M., Nowaczyk, M., & Olejniczak, M. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107737 · Cited by 45
Genetically engineered hypoimmunogenic cell therapy
Hotta, A., Schrepfer, S., & Nagy, A. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00219-9 · Cited by 48
“In addition, precise editing of a single base pair to introduce a stop codon or amino acid change is feasible through homologous recombination 96,157–161 , base editing 162,163 or prime editing 56,164 .”
Rivera-Torres, N., Banas, K. H., Bialk, P. A., Bloh, K. M., & Kmiec, E. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169350 · Cited by 46
CRISPR-based strategies for targeted transgene knock-in and gene correction
Lau, C., Tin, C., & Suh, Y. (2020) · Faculty Reviews · doi:10.12703/r/9-20 · Cited by 51
Precise genome editing without exogenous donor DNA via retron editing system in human cells
Kong, X., Wang, Z., Zhang, R., Wang, X., Zhou, Y., Shi, L., & Yang, H. (2021) · Protein & Cell · doi:10.1007/s13238-021-00862-7 · Cited by 42
Cambri, G., & Mira, M. T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01674 · Cited by 47
“Genomic variants can be edited by CRISPR/Cas9 in the presence of a donor DNA harboring the nucleotide change; after DNA cleavage by Cas9 nuclease, the homology-directed repair machinery is activated and the donor-DNA is inserted (86), creating a feasible strategy to perform in vitro disease modeling with isogenic cont…”
BackgroundRaman, S., Brookhouser, N., & Brafman, D. A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104788 · Cited by 44
Highly efficient generation of sheep with a defined FecBB mutation via adenine base editing
Zhou, S., Ding, Y., Liu, J., Liu, Y., Zhao, X., Li, G., Zhang, C., Li, C., Wang, Y., Kalds, P., et al. (2020) · Genetics Selection Evolution · doi:10.1186/s12711-020-00554-6 · Cited by 53
Rational Selection of CRISPR-Cas9 Guide RNAs for Homology-Directed Genome Editing
Tatiossian, K. J., Clark, R. D. E., Huang, C., Thornton, M. E., Grubbs, B. H., & Cannon, P. M. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.10.006 · Cited by 42
Human iPSC application in Alzheimer’s disease and tau-related neurodegenerative diseases
TCW, J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.043 · Cited by 39
Nassor, F., Jarray, R., Biard, D. S. F., Maïza, A., Papy-García, D., Pavoni, S., Deslys, J., & Yates, F. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00014 · Cited by 42
“Gene editing techniques based on CRISPR-Cas9 in human stem cells (embryonic or induced pluripotent), have been applied to create isogenic cell lines by adding or correcting a mutation (Grobarczyk et al., 2015; Li et al., 2015; Paquet et al., 2016).”
MethodEngineering Point Mutant and Epitope‐Tagged Alleles in Mice Using Cas9 RNA‐Guided Nuclease
Gertsenstein, M., & Nutter, L. M. J. (2018) · Current Protocols in Mouse Biology · doi:10.1002/cpmo.40 · Cited by 42
Wei, R., Yang, J., Cheng, C.-W., Ho, W.-I., Li, N., Hu, Y., Hong, X., Fu, J., Yang, B., Liu, Y., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100389 · Cited by 49
Current advances of CRISPR-Cas technology in cell therapy
Qiu, H.-Y., Ji, R.-J., & Zhang, Y. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100067 · Cited by 41
“While Cas9 could correct a point mutation if presented with a repair donor, the dependence of cell cycling makes it impossible to achieve therapeutic threshold, as most therapeutic relevant cells are non-cycling or slow cycling (Lin et al., 2014; Paquet et al., 2016).”
BackgroundYelagandula, R., Stecher, K., Novatchkova, M., Michetti, L., Michlits, G., Wang, J., Hofbauer, P., Vainorius, G., Pribitzer, C., Isbel, L., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-022-01051-2 · Cited by 41
CRISPR/Cas9 system and its applications in nervous system diseases
Jiang, H., Tang, M.-Y., Xu, Z., Wang, Y., Li, M., Zheng, S., Zhu, J., Lin, Z., & Zhang, M. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.03.017 · Cited by 43
PANoptosis: Cross-Talk Among Apoptosis, Necroptosis, and Pyroptosis in Neurological Disorders
Li, P., Gao, Y., Tao, Z., Mu, Z., Du, S., & Zhao, X. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s526158 · Cited by 42
Shah, R., Cholewa-Waclaw, J., Davies, F. C. J., Paton, K. M., Chaligné, R., Heard, É., Abbott, C. M., & Bird, A. P. (2016) · Wellcome Open Research · doi:10.12688/wellcomeopenres.10011.1 · Cited by 42
“and as expected based on recent findings in hiPSCs (Paquet et al., 2016), no off-target cutting was observed (Figure 2H).”
Efficient Precision Genome Editing in iPSCs via Genetic Co-targeting with Selection
Mitzelfelt, K. A., McDermott‐Roe, C., Grzybowski, M. N., Marquez, M., Kuo, C.-T., Riedel, M. J., Lai, S., Choi, M. J., Kolander, K. D., Helbling, D. C., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.01.021 · Cited by 39
“We speculate, as others have, that the nature and extent of zygosity is dictated by the distance between the CRISPR/Cas9 cut site and the targeted nucleotide as well as locus-dependent factors, such as chromatin organization (Paquet et al., 2016; Ward, 2015; Yang et al., 2013).”
BackgroundWang, B., Wang, Z., Wang, D., Zhang, B., Ong, S., Li, M., Yu, W., & Wang, Y. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0150-y · Cited by 38
Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications
Essayan-Perez, S., Zhou, B., Nabet, A. M., Wernig, M., & Huang, Y. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104503 · Cited by 45
CRISPR/Cas9 Technology: Applications and Human Disease Modeling
Martínez-Lage, M., Torres-Ruiz, R., & Rodríguez, S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.09.002 · Cited by 47
Engineering large-scale chromosomal deletions by CRISPR-Cas9
Eleveld, T. F., Bakali, C., Eijk, P. P., Stathi, P., Vriend, L. E. M., Poddighe, P. J., & Ylstra, B. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab557 · Cited by 43
“In our initial experimental set-up for chromosome 11q, we used a ssDNA template containing homology regions of both locations where DSBs were induced, since it has been suggested that such templates aid in driving repair through homologous recombination (34) and a double strand DNA template would be more prone to lead…”
MethodA combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors
Giulio, S. D., Colicchia, V., Pastorino, F., Pedretti, F., Fabretti, F., di Robilant, V. N., Ramponi, V., Scafetta, G., Moretti, M., Licursi, V., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02003-0 · Cited by 41
“8147 T > C mutation and two additional silent “blocking mutations” on the seed sequence to avoid Cas9 re-cutting [55].”
BackgroundModelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells
Rowland, H. A., Hooper, N. M., & Kellett, K. A. B. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2663-z · Cited by 40
Efficient scarless genome editing in human pluripotent stem cells
Ikeda, K., Uchida, N., Nishimura, T., White, J., Martin, R. M., Nakauchi, H., Sebastiano, V., Weinberg, K. I., & Porteus, M. H. (2018) · Nature Methods · doi:10.1038/s41592-018-0212-y · Cited by 41
Batır, M. B., Şahin, E., & Çam, F. S. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05093-y · Cited by 38
Brink, L., Grandela, C., Mummery, C. L., & Davis, R. P. (2020) · Stem Cells · doi:10.1002/stem.3110 · Cited by 38
“some instances, CRISPR-Cas9 can also prove to be too efficient with biallelic editing occurring at the target site, in which one allele is modified as intended but an insertion or deletion occurs in the other allele due to NHEJ repair.(77) However, overall editing efficiencies are typically between 2% and 10%,(78,79)…”
Liu, Z., Shan, H., Chen, S., Chen, M., Zhang, Q., Lai, L., & Li, Z. (2019) · The FASEB Journal · doi:10.1096/fj.201900476rr · Cited by 38
“Thus, inducing single-nucleotide substitutions in animal genomes can bring great advantages to the researches of diseasemodelingandgene therapy (2, 3).”
BackgroundAndreyev, A. Y., Yang, H., Doulias, P., Dolatabadi, N., Zhang, X., Luevanos, M., Blanco, M., Baal, C., Putra, I., Nakamura, T., et al. (2024) · Advanced Science · doi:10.1002/advs.202306469 · Cited by 37
PLK1-mediated phosphorylation of WDR62/MCPH2 ensures proper mitotic spindle orientation
Miyamoto, T., Akutsu, S. N., Fukumitsu, A., Morino, H., Masatsuna, Y., Hosoba, K., Kawakami, H., Yamamoto, T., Shimizu, K., Ohashi, H., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx330 · Cited by 35
“This method enables the efficient generation of heterozygous human cultured cells, although it needs two genome editing steps (21).”
MethodLiu, S., Wang, Q., Yu, X., Li, Y., Guo, Y., Liu, Z., Sun, F., Hou, W., Li, C., Wu, L. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26894-4 · Cited by 40
Xie, Y., Ng, N. N., Safrina, O., Ramos, C. M., Ess, K. C., Schwartz, P. H., Smith, M. A., & O’Dowd, D. K. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104627 · Cited by 36
Human induced pluripotent stem cells as a research tool in Alzheimer's disease
Robbins, J. P., & Price, J. (2017) · Psychological Medicine · doi:10.1017/s0033291717002124 · Cited by 36
“iPSC lines with fAD mutations have been generated, displaying genotype-dependent disease-associated phenotypes in the differentiated cortical neurons (Paquet et al. 2016).”
BackgroundGenetic Variants and Oxidative Stress in Alzheimer’s Disease
Kowalska, M., Wize, K., Prendecki, M., Lianeri, M., Kozubski, W. P., & Dorszewska, J. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200224121447 · Cited by 36
Johne's Disease in Dairy Cattle: An Immunogenetic Perspective
Mallikarjunappa, S., Brito, L. F., Pant, S. D., Schenkel, F. S., Meade, K. G., & Karrow, N. A. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.718987 · Cited by 34
Strategies for precise gene edits in mammalian cells
Fichter, K. M., Setayesh, T., & Malik, P. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.04.012 · Cited by 37
“However, it is important to note that one can avoid continual cleavage by using a donor that, when incorporated into the repair, mutates the PAM or the gRNA target sequence (protospacer), inhibiting Cas9 from recognizing and cutting the site again.(8) Another complicating factor is that DSBs cut by Cas9 are created as…”
BackgroundFunctional interrogation of non-coding DNA through CRISPR genome editing
Canver, M. C., Bauer, D. E., & Orkin, S. H. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.008 · Cited by 39
Dynamics of Indel Profiles Induced by Various CRISPR/Cas9 Delivery Methods
Kosicki, M., Rajan, S. S., Lorenzetti, F. C., Wandall, H. H., Narimatsu, Y., Metzakopian, E., & Bennett, E. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.09.003 · Cited by 35
Modelling Alzheimer's disease: Insights fromin vivotoin vitrothree-dimensional culture platforms
Ranjan, V., Qiu, L., Tan, E., Zeng, L., & Zhang, Y. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2728 · Cited by 46
The genomics of schizophrenia: Shortcomings and solutions
Zhuo, C., Hou, W., Li, G., Mao, F., Li, S., Lin, X., Jiang, D., Xu, Y. J., Tian, H., Wang, W., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.03.009 · Cited by 38
Khan, M. S., Qureshi, N., Khan, R., Son, Y., & Maqbool, T. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1578138 · Cited by 38
Lu, S., Shen, X., & Chen, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-03233-7 · Cited by 35
Henser‐Brownhill, T., Monserrat, J., & Scaffidi, P. (2017) · Epigenetics · doi:10.1080/15592294.2017.1395121 · Cited by 37
Simple and reliable detection of CRISPR-induced on-target effects by qgPCR and SNP genotyping
Weisheit, I., Kroeger, J. A., Malik, R., Wefers, B., Lichtner, P., Wurst, W., Dichgans, M., & Paquet, D. (2021) · Nature Protocols · doi:10.1038/s41596-020-00481-2 · Cited by 39
Self-citationStazio, M. D., Foschi, N., Athanasakis, E., Gasparini, P., & D’Adamo, P. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247603 · Cited by 33
“In the fast-evolving field of gene editing using CRISPR/Cas9, crucial efforts to improve the efficiency of HDR have been made; but the reported success rates remained very low in many cell type and in vivo studies [5, 10, 11].”
BackgroundTian, R., Liu, J., Fan, W., Li, R., Cui, Z., Jin, Z., Huang, Z., Xie, H., Li, L., Huang, Z., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.12.011 · Cited by 33
Challenges of CRISPR-Based Gene Editing in Primary T Cells
Rezalotfi, A., Fritz, L. V., Förster, R., & Bošnjak, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031689 · Cited by 37
Cengic, I., Cañadas, I. C., Minton, N. P., & Hudson, E. P. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00375 · Cited by 36
Shakirova, A. I., Karpov, T. E., Komarova, Y., & Lepik, K. V. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1068637 · Cited by 34
FTO demethylase activity is essential for normal bone growth and bone mineralization in mice
Sachse, G., Church, C., Stewart, M. E., Cater, H. L., Teboul, L., Cox, R., & Ashcroft, F. M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.11.027 · Cited by 33
“1A), the guide fails to efficiently target the site after genomic exchange has happened [22].”
BackgroundHighly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells
Kornete, M., Marone, R., & Jeker, L. T. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701121 · Cited by 36
CRISPR/Cas9—Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development
Okoli, A. S., Okeke, M. I., Tryland, M., & Moens, U. L. (2018) · Viruses · doi:10.3390/v10010050 · Cited by 40
“Thus, during repair by this pathway, substitutions, insertions and deletions (indels) often occur leading to frameshift or premature stop codon that can inactivate the gene [49,50].”
BackgroundUrine-derived induced pluripotent stem cells as a modeling tool to study rare human diseases
Shi, L., Cui, Y., Luan, J. Y., Zhou, X., & Han, J. (2016) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2016.01062 · Cited by 35
“A recent study efficiently introduced specific point mutations with CRISPR/Cas9 and it edited just one copy of a gene, rather than both copies (96).”
BackgroundCRISPR and Target-Specific DNA Endonucleases for Efficient DNA Knock-in in Eukaryotic Genomes.
Lee, S. H., Kim, S., & Hur, J. K. (2018) · PubMed Central · doi:10.14348/molcells.2018.0408 · Cited by 33
“4G), in which exogenous donor DNA (ssODN) contains “blocking sequences” that are mismatch DNA sequences that prevent DNA re-cleavage after knock-in in order to reduce insertion and deletion (indel) formation (Paquet et al., 2016).”
BackgroundLizarraga, S. B., Ma, L., Maguire, A. M., van Dyck, L. I., Wu, Q., Ouyang, Q., Kavanaugh, B. C., Nagda, D., Livi, L. L., Pescosolido, M. F., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw0682 · Cited by 35
Li, J., Kong, D., Ke, Y., Zeng, W., & Miki, D. (2024) · BMC Biology · doi:10.1186/s12915-024-01810-7 · Cited by 38
“Thus, it suggests that the HDR mechanism may be more predominant when short deletions due to overlapping sgRNAs occur [36, 37].”
BackgroundSupharattanasitthi, W., Carlsson, E., Sharif, U., & Paraoan, L. (2019) · Scientific Reports · doi:10.1038/s41598-018-36740-2 · Cited by 32
Reich, M., Simon, M. J., Polke, B., Paris, I., Werner, G., Schrader, C. M., Spieth, L., Davis, S. S., Robinson, S., de Melo, G. L., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj7308 · Cited by 37
“S15) ( 20 , 57 , 58 ).”
Self-citationWays of improving precise knock-in by genome-editing technologies
Smirnikhina, S., Anuchina, A. A., & Лавров, А. В. (2018) · Human Genetics · doi:10.1007/s00439-018-1953-5 · Cited by 32
Coiled-coil heterodimer-based recruitment of an exonuclease to CRISPR/Cas for enhanced gene editing
Lainšček, D., Forstnerič, V., Mikolič, V., Malenšek, Š., Pečan, P., Benčina, M., Sever, M., Podgornik, H., & Jerala, R. (2022) · Nature Communications · doi:10.1038/s41467-022-31386-1 · Cited by 38
Metadata
- Authors
- Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M.
- Affiliations
- Rockefeller University (US)
- New York Stem Cell Foundation (US)
- Cornell University (US)
- Venue
- Nature
- Published
- 2016-04-27
- Volume
- 533
- Issue
- 7601
- Pages
- 125-129
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2343876552
- Cited by
- 951
- References
- 49
- Citations by year
- 2026: 58 · 2025: 56 · 2024: 90 · 2023: 87 · 2022: 104 · 2021: 106 · 2020: 125 · 2019: 93 · 2018: 111 · 2017: 91 · 2016: 29
- FWCI
- 56.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000043)
- National Institute of General Medical Sciences (T32GM007739)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, homology-directed repair, non-homologous end joining, amyloid precursor protein, presenilin 1, early-onset Alzheimer's disease, induced pluripotent stem cells, disease modeling
- MeSH terms
- RNA, Guide, CRISPR-Cas Systems, Adolescent, Alleles, Alzheimer Disease, Animals, Base Sequence, DNA Repair, Female, Genes, Dominant, Genetic Engineering, Heterozygote, Homozygote, Humans, Male, Mutation, Substrate Specificity, Templates, Genetic, Mutagenesis, Amyloid beta-Protein Precursor, Sequence Homology, Age of Onset, Mice, Presenilins, DNA Cleavage, DNA Breaks, Double-Stranded, Genetic Association Studies, Induced Pluripotent Stem Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.